Celcuity (CELC) Cash & Current Investments (2016 - 2025)
Celcuity (CELC) reported Cash & Current Investments of $717.3 million for Q4 2025, up 205.12% on a YoY basis from $235.1 million in Q4 2024, and up 57.65% quarter-over-quarter from $455.0 million in Q3 2025.
Celcuity (CELC) Cash & Current Investments (2016 - 2025) Analysis & Trends
Celcuity has reported Cash & Current Investments for 10 years, with the latest figure at $717.3 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Current Investments rose 205.12% year-over-year to $717.3 million; the trailing twelve-month figure through Dec 2025 stood at $717.3 million (up 205.12% YoY), and the FY2025 full-year result was $717.3 million, up 205.12% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $717.3 million, up from $455.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $717.3 million in Q4 2025, with the low at $32.3 million in Q2 2023.
- Historically, Cash & Current Investments has averaged $175.5 million across 5 years, with a median of $151.2 million in 2023.
- Annual changes were most pronounced in 2023 — Cash & Current Investments slumped 57.02% — and 2024, when it surged 777.44%.
- Celcuity's Cash & Current Investments stood at $84.3 million in 2021, then surged by 99.97% to $168.6 million in 2022, then rose by 7.12% to $180.6 million in 2023, then surged by 30.18% to $235.1 million in 2024, then soared by 205.12% to $717.3 million in 2025.
- The last three Cash & Current Investments figures came in at $717.3 million (Q4 2025), $455.0 million (Q3 2025), and $168.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 717.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 717.29 Mn |
| Sep 30, 2025 | 454.98 Mn |
| Jun 30, 2025 | 168.39 Mn |
| Mar 31, 2025 | 205.69 Mn |
| Dec 31, 2024 | 235.09 Mn |
| Sep 30, 2024 | 264.06 Mn |
| Jun 30, 2024 | 283.07 Mn |
| Mar 31, 2024 | 177.66 Mn |
| Dec 31, 2023 | 180.58 Mn |
| Sep 30, 2023 | 133.94 Mn |
| Jun 30, 2023 | 32.26 Mn |
| Mar 31, 2023 | 33.66 Mn |
| Dec 31, 2022 | 168.59 Mn |
| Sep 30, 2022 | 57.51 Mn |
| Jun 30, 2022 | 66.93 Mn |
| Mar 31, 2022 | 78.32 Mn |
| Dec 31, 2021 | 84.31 Mn |
| Sep 30, 2021 | 90.39 Mn |
| Jun 30, 2021 | 41.66 Mn |
| Mar 31, 2021 | 34.96 Mn |